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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPERHigh-Sensitivity CRP and Cardiovascular Disease 397
Omair Yousuf, Bibhu D. Mohanty, Seth S. Martin, Parag H. Joshi, Michael J. Blaha, Khurram Nasir,
Roger S. Blumenthal, Matthew J. Budoff
The role of inﬂammation is central to the initiation and progression of atherothrombosis.
Of the inﬂammatory biomarkers, high-sensitivity C-reactive protein (hsCRP) has received
the most attention. In this state-of-the-art paper, the authors provide a comprehensive review
of hsCRP. Speciﬁcally they discuss: 1) the biology of hsCRP and its role in atherosclerosis;
2) the epidemiological association of hsCRP with CVD; 3) the quality of hsCRP as a
biomarker of risk; and 4) the use of hsCRP as a tool to initiate or tailor statin therapy.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGYEtiology of 30-Day Mortality After PCI 409
Bhuvnesh Aggarwal, Stephen G. Ellis, A. Michael Lincoff, Samir R. Kapadia, Joseph Cacchione,
Russell E. Raymond, Leslie Cho, Christopher Bajzer, Ravi Nair, Irving Franco, Conrad Simpfendorfer,
E. Murat Tuzcu, Patrick L. Whitlow, Mehdi H. Shishehbor
This study reports on the causes of death and the incidence of percutaneous intervention
(PCI)-related mortality within 30 days. All patients who died within 30 days (single-center,
January 2009 to April 2011) were included and cause of death was ascertained. Of the 4,078
PCIs, 81 deaths (2%) occurred within 30 days. Of these, 58% died of cardiac and 42%
noncardiac causes with only 42% of 30-day deaths attributed to PCI-related complications.
Death certiﬁcates had only 58% accuracy for classifying patients as experiencing cardiac
versus noncardiac death. The authors concluded that less than one-half of 30-day deaths are
attributed to PCI-related complications and death certiﬁcates are inaccurate and do not
report PCI-related death.
Editorial Comment: Duane S. Pinto, Yuri B. Pride, p. 416(continued on page A-20)
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Raj R. Makkar, Hasan Jilaihawi, Tarun Chakravarty, Gregory P. Fontana, Samir Kapadia,
Vasilis Babaliaros, Wen Cheng, Vinod H. Thourani, Joseph Bavaria, Lars Svensson, Susheel Kodali,
Takahiro Shiota, Robert Siegel, E. Murat Tuzcu, Ke Xu, Rebecca T. Hahn, Howard C. Herrmann,
Mark Reisman, Brian Whisenant, Scott Lim, Nirat Beohar, Michael Mack, Paul Teirstein,
Charanjit Rihal, Pamela S. Douglas, Eugene Blackstone, Augusto Pichard, John G. Webb, Martin B. Leon
Transcatheter aortic valve replacement (TAVR) failure with acute insertion of a second
transcatheter prosthetic valve (TV) within the ﬁrst (TV-in-TV) or transcatheter valve
embolization (TVE) can occur as a consequence of TAVR malpositioning. This study sought
to determine the cause and outcome of both of these types of TAVR failures. Patients
undergoing TAVR in the PARTNER randomized trial (cohort A and B) were studied.
From a total of 2,554 consecutive patients, 63 (2.47%) experienced TV-in-TV and
26 (1.01%) experienced TVE. TV-in-TV was an independent predictor of 1-year
cardiovascular mortality (HR: 1.86, p ¼ 0.041). Multivariate analysis found TVE to be an
independent predictor of 1-year mortality (HR: 2.68, p ¼ 0.0055) but not cardiovascular
mortality. The authors conclude that acute TV-in-TV and TVE carry an excess mortality and
are caused by anatomic and technical factors.Computed Tomography Area Sizing for TAVR 431Ronald K. Binder, John G. Webb, Alexander B. Willson, Marina Urena, Nicolaj C. Hansson,
Bjarne L. Norgaard, Philippe Pibarot, Marco Barbanti, Eric Larose, Melanie Freeman, Eric Dumont,
Chris Thompson, Miriam Wheeler, Robert R. Moss, Tae-hyun Yang, Sergio Pasian, Cameron J. Hague,
Giang Nguyen, Rekha Raju, Stefan Toggweiler, James K. Min, David A. Wood, Josep Rodés-Cabau,
Jonathon Leipsic
The authors prospectively investigate the impact of integration of a multidetector computed
tomography (MDCT) annular area sizing algorithm (goal of modest annulus area oversizing
of 5% to 10%) on transcatheter aortic valve replacement (TAVR) outcomes. Of 266 patients,
133 consecutive patients underwent TAVR (SAPIEN XT Transcatheter heart valve,
Edwards Lifesciences, Irvine, California) in the MDCT group and 133 consecutive patients
in the control group (annular size based on transesophageal echocardiography and
angiography). More than mild paravalvular regurgitation (PAR) was present in 5.3%
(7 of 133) in the MDCT group and in 12.8% (17 of 133) in the control group (p ¼ 0.032).
The secondary endpoint (composite of in-hospital deaths, aortic annulus rupture, and severe
PAR) occurred in 3.8% (5 of 133) in the MDCT group and in 11.3% (15 of 133) in the
control group (p ¼ 0.02) driven by a difference in severe PAR. The authors conclude that
implementation of a MDCT annulus area sizing algorithm for TAVR reduces PAR.(continued on page A-21)
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Bimal R. Shah, Lisa A. McCoy, Jerome J. Federspiel, Daniel Mudrick, Patricia A. Cowper,
Frederick A. Masoudi, Barbara L. Lytle, Cynthia L. Green, Pamela S. Douglas
The authors report on the patterns of diagnostic testing after percutaneous coronary
intervention (PCI) in the United States and the relationship of these patterns with clinical
outcomes (using the National Cardiovascular Data Registry, Cath PCI registry from 2005 to
2007). A total of 247,052 patients underwent PCI at 656 institutions. There was 9% and
20% higher adjusted risk of repeat revascularization in quartile 3 and quartile 4 (higher
testing rate), respectively, when compared to quartile 1 (lowest testing rate) (p ¼ 0.020 and
p < 0.0001, respectively). The adjusted risk for death and acute myocardial infarction did not
differ among quartiles of diagnostic testing. The authors conclude that while patient
characteristics were largely independent of rates of post-PCI testing, higher testing rates were
not associated with lower risk of myocardial infarction or death but repeat revascularization
was signiﬁcantly higher at these diagnostic testing sites.
Editorial Comment: Mark A. Hlatky, Anthony N. DeMaria, p. 447CARDIOMYOPATHYObesity and LV Mass in HCM 449Iacopo Olivotto, Barry J. Maron, Benedetta Tomberli, Evan Appelbaum, Carol Salton,
Tammy S. Haas, C. Michael Gibson, Stefano Nistri, Eleonora Servettini, Raymond H. Chan,
James E. Udelson, John R. Lesser, Franco Cecchi, Warren J. Manning, Martin S. Maron
The authors report on a study to assess the impact of body mass index (BMI) on disease
expression and clinical course in a multicenter hypertrophic cardiomyopathy cohort. A total
of 275 adult hypertrophic cardiomyopathy (HCM) patients (age 48  14 years) underwent
cardiovascular magnetic resonance (CMR) and were followed for heart failure progression.
Multivariate analysis showed that pre-obese and obese HCM patients (BMI 25 to 30 and
>30 kg/m2, respectively) had a 65% and 310% increased likelihood of left ventricular mass in
the highest quartile (>120 g/m3) compared to normal weight patients (BMI <25 kg/m2).
Proportion of patients in New York Heart Association functional class III at the end of
follow-up was 13% among obese patients compared to 6% among those of normal weight
(p ¼ 0.03). In HCM patients, extrinsic factors, such as obesity, are independently associated
with increase in left ventricular mass and may dictate progression of heart failure symptoms.
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Coronary lesions of intermediate stenosis demonstrate signiﬁcant rates of ischemia. The
authors evaluate the performance of percent aggregate coronary plaque volume (%APV)
representing cumulative plaque volume as a function of total vessel volume for identiﬁcation
of ischemic lesions of intermediate stenosis severity. Fifty-eight individuals undergoing
computed tomography angiography (CTA) were identiﬁed with intermediate lesions (30% to
69% stenosis). Patients underwent additional CTA measures including minimal lumen
diameter (MLD), minimal lumen area (MLA), and %APV. Patients subsequently underwent
angiography including fractional ﬂow reserve (FFR) evaluation. In 58 lesions, 22 (38%)
caused ischemia (FFR <0.80). Area under the receiver-operating characteristic curve (AUC)
was used to examine discrimination (for different coronary CTA parameters) and was highest
for %APV (0.88) compared to diameter stenosis (0.68), area stenosis (0.55), MLD (0.75), or
MLA (0.78). The authors concluded that compared to diameters stenosis, area stenosis,
MLD, and MLA, %APV by coronary CTA improves identiﬁcation, discrimination, and
reclassiﬁcation of ischemic lesions of intermediate stenosis severity.Optimized Prognostic Score for Coronary CTA 468
Martin Hadamitzky, Stephan Achenbach, Mouaz Al-Mallah, Daniel Berman, Matthew Budoff,
Filippo Cademartiri, Tracy Callister, Hyuk-Jae Chang, Victor Cheng, Kavitha Chinnaiyan,
Benjamin J. W. Chow, Ricardo Cury, Augustin Delago, Allison Dunning, Gudrun Feuchtner,
Millie Gomez, Philipp Kaufmann, Yong-Jin Kim, Jonathon Leipsic, Fay Y. Lin, Erica Maffei,
James K. Min, Gil Raff, Leslee J. Shaw, Todd C. Villines, Jörg Hausleiter, for the CONFIRM
Investigators
The objective of this study was to analyze the predictive value of coronary computed
tomography angiography (CCTA) and to model and validate an optimized score for
prognosis of 2-year survival based on patient population with suspected coronary artery
disease. Using a test sample of 17,793 patients (CONFIRM registry) and a validation sample
of 2,506 patients with suspected coronary artery disease and based on CCTA data and
clinical risk score, an optimized score was developed. During a median follow-up of 2.3 years,
347 patients died. The best CCTA parameter for prediction of mortality was the number of
proximal segments with mixed or calciﬁed plaque and the number of proximal segments with
stenosis >50%. In an optimizing score including both these parameters, CCTA signiﬁcantly
improved overall risk prediction beyond NCEP ATP III score. The authors concluded that
in CCTA both plaque burden and stenosis particularly in the proximal segment carried
incremental prognostic value.
Editorial Comment: John F. Younger, p. 477
